Annie Wong

1.6k total citations · 1 hit paper
20 papers, 1.0k citations indexed

About

Annie Wong is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Annie Wong has authored 20 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Molecular Biology. Recurrent topics in Annie Wong's work include Cancer Immunotherapy and Biomarkers (13 papers), CAR-T cell therapy research (6 papers) and Brain Metastases and Treatment (3 papers). Annie Wong is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), CAR-T cell therapy research (6 papers) and Brain Metastases and Treatment (3 papers). Annie Wong collaborates with scholars based in Australia, New Zealand and United States. Annie Wong's co-authors include Matteo S. Carlino, Alexander M. Menzies, Oliver Klein, John Park, Georgina V. Long, Grant A. McArthur, Jennifer L. McQuade, Michael A. Davies, Shahneen Sandhu and Douglas B. Johnson and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

Annie Wong

20 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab

2016 604 citations Alexander M. Menzies, Douglas B. Johnson et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Annie Wong Australia	11	862	274	208	139	124	20	1.0k
Ewa Kalinka‐Warzocha Poland	18	504 0.6×	363 1.3×	187 0.9×	92 0.7×	160 1.3×	91	944
Michael Method United States	18	667 0.8×	210 0.8×	159 0.8×	64 0.5×	204 1.6×	73	1.3k
Dimitri Korol Switzerland	16	322 0.4×	162 0.6×	103 0.5×	143 1.0×	188 1.5×	42	742
Tracy Proverbs‐Singh United States	7	688 0.8×	268 1.0×	195 0.9×	39 0.3×	210 1.7×	14	1.1k
Geoffrey Fell United States	15	343 0.4×	118 0.4×	114 0.5×	213 1.5×	135 1.1×	46	862
M. Puglisi Italy	16	539 0.6×	408 1.5×	90 0.4×	55 0.4×	257 2.1×	38	998
Mark Cornfeld United States	11	497 0.6×	151 0.6×	157 0.8×	67 0.5×	294 2.4×	33	838
Capucine Baldini France	16	686 0.8×	280 1.0×	172 0.8×	39 0.3×	140 1.1×	89	964
Sara Kinhult Sweden	11	423 0.5×	400 1.5×	77 0.4×	279 2.0×	65 0.5×	28	809
Juliana Di Iulio Australia	16	645 0.7×	223 0.8×	103 0.5×	254 1.8×	318 2.6×	34	1.1k

Countries citing papers authored by Annie Wong

Since Specialization

Citations

This map shows the geographic impact of Annie Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annie Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annie Wong more than expected).

Fields of papers citing papers by Annie Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annie Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annie Wong. The network helps show where Annie Wong may publish in the future.

Co-authorship network of co-authors of Annie Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Annie Wong. A scholar is included among the top collaborators of Annie Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annie Wong. Annie Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

John, Thomas, et al.. (2024). Biomarkers for immunotherapy resistance in non-small cell lung cancer. Frontiers in Oncology. 14. 1489977–1489977. 6 indexed citations

McLachlan, Jennifer, et al.. (2024). Real-World Outcomes of Immunotherapy for Melanoma Brain Metastases in New Zealand. JCO Oncology Practice. 21(3). 358–364. 1 indexed citations

Taylor, Jennifer M., et al.. (2022). Pembrolizumab-induced Myasthenia Gravis: Literature Review of Ocular Manifestations and a Refractory Case. Journal of Immunotherapy. 45(6). 267–273. 7 indexed citations

Wong, Annie, Jason Callahan, Marleen Keyaerts, et al.. (2020). 18F-FDG PET/CT based spleen to liver ratio associates with clinical outcome to ipilimumab in patients with metastatic melanoma. Cancer Imaging. 20(1). 36–36. 48 indexed citations

Wong, Annie, et al.. (2019). Balancing the Hype with Reality: What Do Patients with Advanced Melanoma Consider When Making the Decision to Have Immunotherapy?. The Oncologist. 24(11). e1190–e1196. 33 indexed citations

Wong, Annie, et al.. (2018). Brain Metastases in Non-Small-Cell Lung Cancer: Are Tyrosine Kinase Inhibitors and Checkpoint Inhibitors Now Viable Options?. Current Oncology. 25(11). 103–114. 39 indexed citations

Wong, Annie, et al.. (2018). Outcomes of Australian patients receiving non‐funded anti‐PD‐1 immune checkpoint inhibitors for non‐melanoma cancers. Asia-Pacific Journal of Clinical Oncology. 14(4). 337–342. 3 indexed citations

Wong, Annie, Grant A. McArthur, Michael S. Hofman, & Rodney J. Hicks. (2017). The Advantages and Challenges of Using FDG PET/CT for Response Assessment in Melanoma in the Era of Targeted Agents and Immunotherapy. European Journal of Nuclear Medicine and Molecular Imaging. 44(S1). 67–77. 82 indexed citations

Parakh, Sagun, John Park, Shehara Mendis, et al.. (2017). Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases. British Journal of Cancer. 116(12). 1558–1563. 81 indexed citations

10.

Wong, Annie, et al.. (2017). Clinical and palliative care outcomes for patients of poor performance status treated with antiprogrammed death‐1 monoclonal antibodies for advanced melanoma. Asia-Pacific Journal of Clinical Oncology. 13(6). 385–390. 19 indexed citations

11.

Boyle, Samantha E., Clare G. Fedele, Vincent Corbin, et al.. (2016). CD271 Expression on Patient Melanoma Cells Is Unstable and Unlinked to Tumorigenicity. Cancer Research. 76(13). 3965–3977. 24 indexed citations

12.

Menzies, Alexander M., Douglas B. Johnson, Sangeetha Ramanujam, et al.. (2016). Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab. Annals of Oncology. 28(2). 368–376. 604 indexed citations breakdown →

13.

Menzies, Alexander M., Douglas B. Johnson, Sangeetha Ramanujam, et al.. (2016). Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders (AD) or major toxicity with ipilimumab (IPI).. Journal of Clinical Oncology. 34(15_suppl). 9515–9515. 14 indexed citations

14.

Wong, Annie, Jason Callahan, Alan Herschtal, et al.. (2016). Spleen to liver ratio (SLR): Novel PET imaging biomarker for prediction of overall survival after ipilimumab and anti-PD1 in patients with metastatic melanoma.. Journal of Clinical Oncology. 34(15_suppl). 9523–9523. 7 indexed citations

15.

Wong, Annie, et al.. (2015). Permission Granted: A Case Study of the Challenges and Opportunities of Creating Community Experiences at the Gladstone Hotel. Curator The Museum Journal. 58(1). 91–99. 1 indexed citations

16.

Jacobson, Kathleen, et al.. (2012). Developing the HIV Workforce: A Case Study of a Training Model for Inexperienced HIV Providers. Journal of Health Care for the Poor and Underserved. 23(4). 1502–1511. 3 indexed citations

17.

Elder, Dawn E., Annie Wong, & Jane Zuccollo. (2009). Risk factors for and timing of death of extremely preterm infants. Australian and New Zealand Journal of Obstetrics and Gynaecology. 49(4). 407–410. 7 indexed citations

18.

Wong, Annie, Dawn E. Elder, & Jane Zuccollo. (2008). Changes in cause of neonatal death over a decade.. PubMed. 121(1277). 39–46. 5 indexed citations

19.

Taylor, William J., Annie Wong, Richard J. Siegert, & Harry McNaughton. (2006). Effectiveness of a clinical pathway for acute stroke care in a district general hospital: an audit. BMC Health Services Research. 6(1). 16–16. 22 indexed citations

20.

Wong, Annie, et al.. (2005). DEVELOPING MANAGERIAL EFFECTIVENESS: ASSESSING AND COMPARING THE IMPACT OF DEVELOPMENT PROGRAMMES USING A MANAGEMENT SIMULATION OR A MANAGEMENT GAME. Developments in Business Simulation and Experiential Learning: Proceedings of the Annual ABSEL conference. 32. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact